The European Commission has recently published the communication on the EU Drugs Agenda and Action Plan (2021-2025), a proposal for setting out the political framework, priorities and actions for implementing EU drugs policy over the next 5 years. The CSFD, as an expert group of the European Commission, has been included in the evaluation process of the EU Drug Strategy 2013-2020. It also has been consulted directly once, in early April 2020, to provide input on the new EU Agenda on Drugs, on the top of the possibility for the CSFD members to contribute to the process through the open public consultation (lasting from 10 June to 15 July 2020) regarding the Roadmap for reshaping the EU drug policy with the new Drugs Agenda. Read the full response here.
